After excluding MYO1G CpGs from Score-15, the positive association with lung cancer risk (10 of 13 CpGs available, OR = 1.15, 95% CI = 0.93–1.44) was attenuated relative to the association for the original Score-15. This evidence concerns the gene MYO1G and lung carcinoma.